Peptide Therapeutics Foundation is categorized under Clubs in San Diego, CA and active since 2010.
Peptide Therapeutics Foundation was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Clubs business, which does work in the BOTH market, and is classified as a Clubs, under code number 813410 by the NAICS.
If you are seeking more information, feel free to contact Richard Dimarchi at the company’s single location by writing to 4245 Sorrento Valley Boulevard, San Diego, California CA 92121 or by phoning (858) 657-1511. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Peptide Therapeutics Foundation |
| Contact Person: | Richard Dimarchi |
| Address: | 4245 Sorrento Valley Boulevard, San Diego, California 92121 |
| Phone Number: | (858) 657-1511 |
| Website Address: | peptidetherapeutics.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Clubs |
| SIC Code: | 8641 |
| NAICS Code: | 813410 |
| Share This Business: |
Peptide Therapeutics Foundation was started in 2010 to provide professional Clubs under the SIC code 8641 and NAICS code 813410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Dimarchi for inquiries that concern Peptide Therapeutics Foundation by calling the company number (858) 657-1511, as your correspondence is most welcome. Additionally, the physical location of the single location of Peptide Therapeutics Foundation can be found at the coordinates 32.905266,-117.213868 as well as the street address 4245 Sorrento Valley Boulevard in San Diego, California 92121.
For its online presence, you may visit Peptide Therapeutics Foundation’s website at peptidetherapeutics.org and engage with its social media outlets through on Twitter and on Facebook.